Coronavirus (COVID-19) - Latest Information for Patients and Visitors

(La más reciente información para pacientes y visitantes)

 

Read Now (Lea ahora)
SEARCH TEMPLE HEALTH
Lung Center

Temple Lung Center Faculty at the 2020 ATS Conference

Internationally renowned pulmonologist Gerard Criner, MD — board member for the Global Initiative for Chronic Obstructive Lung Disease (GOLD), a co-author of the GOLD strategy, and Director of the Temple Lung Centerin Philadelphia, Pennsylvania — and his pulmonology team published 68 abstracts.

Abstracts

Effect Of Illness Severity On Mortality Among Sarcoidosis Patients Listed For Lung Transplantation
A.J. Gangemi, M. Zheng, C.N. Myers, H. Zhao, K. Mittal, F.C. Cordova, G.J. Criner, R. Gupta, and A.J. Mamary

Absence Of Pleural Sliding On Ultrasound Correlates To Degree Of Emphysematous Destruction
A.J. Gangemi, M. Patel, P.B. Desai, J. Thomas, L.-Y.H. Criner, V. Kim, N. Marchetti, and G.J. Criner

Influence Of Sex On The Association Between Carbon Monoxide With Sleep Disturbances In African Americans
A.J. Gangemi, A. Satti, R.I. Blair, A. Kambo, B. Brewer, M. Zantah, G. Ma, M. Grandner, G.J. Criner, and F. Patterson

Ventilation Shifts Following Bronchoscopic Lung Volume Reduction To Regions Of Normal Lung Compliance
A.J. Gangemi, S. Dadparvar, R. Patel, H. Zhao, E. Dominguez Castillo, M. Zantah, J. Thomas, L.-Y.H. Criner, N. Patlakh, Z. Dorey-Stein, M. Patel, M. Zheng, C. Dass, N. Marchetti, and G.J. Criner

Endobronchial Obstruction By Fibrotic Webbing In A Patient With Sarcoidosis And Mycobacterium Avium
K.U. Lio, A.J. Gangemi, and E. Narewski

The Six-Minute Walk Test In Sarcoidosis Associated Pulmonary Hypertension: Results From An International Registry
R. Gupta, R.P. Baughman, S.D. Nathan, A.U. Wells, V. Kouranos, E.H. Alhamad, D.A. Culver, J. Barney, E.M. Carmona Porquera, M. Huitema, M.B. Scholand, M. Wijsenbeek, S. Ganesh, S.S. Birring, and O.A. Shlobin

Pirfenidone for Fibrotic Sarcoidosis: Physiology of Study Patients
R. Gupta, R.P. Baughman, M.A. Judson, R. Reeves, E. Lower, and A.U. Wells

Pneumothorax and Lung Volume Reduction After Endobronchial Valve Placement
E. Dominguez Castillo, M. Zantah, A.J. Gangemi, A. Pandya, M. Zheng, Z. Dorey-Stein, M. Patel, N.J. Patlakh, J. Thomas, L.-Y.H. Criner, N. Marchetti, and G.J. Criner

Effect of Bronchoscopic Lung Volume Reduction (BLVR) on Resting Heart Rate in Patients with Severe Hyperinflation and Advanced Emphysema
E. Dominguez Castillo, M. Zantah, A. Pandya, M. Patel, R. Marron, S. Verga, I. Yousef, Z. Dorey-Stein, A.J. Gangemi, M. Zheng, L.-Y.H. Criner, N.J. Patlakh, J. Thomas, N. Marchetti, and G.J. Criner

Smoking Cessation Intentions and Treatment Preferences in African American versus Smokers of Other Racial Backgrounds
M. Zantah, A.J. Gangemi, R.I. Blair, A. Satti, and F. Patterson

Improvement In DLCO Following Bronchoscopic Lung Volume Reduction Therapy
M. Zantah, A. Pandya, E. Dominguez Castillo, Z. Dorey-Stein, M. Patel, M. Zheng, A.J. Gangemi, L.-Y.H. Criner, J. Thomas, N. Patlakh, N. Marchetti, F. Jaffe, and G.J. Criner

Lung Denervation and Its Effect on Breathlessness, Cough and Sputum Scale in Patients Following Lung Transplantation
M. Zantah, N. Marchetti, M.R. Jacobs, and G.J. Criner

Lung Denervation And Its Effect On Bronchial Responsiveness Following Lung Transplant Surgery
M. Zantah, A. Pandya, N. Marchetti, M.R. Jacobs, and G.J. Criner

Effectiveness of Bronchoscopic Lung Volume Reduction with Endobronchial Valves in Clinical Practice
M. Zantah, A.J. Gangemi, E. Dominguez Castillo, A. Pandya, Z.L. Dorey-Stein, M. Patel, M. Zheng, J. Thomas, N. Patlakh, L.-Y.H. Criner, N. Marchetti, and G.J. Criner

Change In Lobar Perfusion Following Bronchoscopic Lung Volume Reduction (BLVR) Treatment and Its Impact on Gas Exchange
M. Zantah, R. Patel, A.J. Gangemi, P. Nicole, J. Thomas, E. Dominguez Castillo, S. Dadparvar, C. Dass, and G.J. Criner

Redistribution of Perfusion from BLVR Targeted Lobe to Ipsilateral Non-Targeted Lobe Improves Oxygenation Independent of Lobar Volume Reduction
M. Zantah, E. Dominguez Castillo, R. Patel, S. Dadparvar, N. Marchetti, G.J. Criner, and C. Dass

Does the Development of CKD Post-Lung Transplantation Affect Mortality?
C.N. Myers, S. Priest, R. Marron, M. Patel, Z. Dorey-Stein, J. Chowdhury, S. Codella, N. Mills, P. Varghese, H. Zhao, P. Mulhall, J. Galli, K.V. Shenoy, S. Sehgal, N. Marchetti, F.C. Cordova, G.J. Criner, A.J. Mamary, J.C. Brown

Hospital Resource Utilization Following Bronchoscopic Lung Volume Reduction (BLVR) with Endobronchial Valves in Clinical Practice
N. Marchetti, A. Rastogi, N.J. Patlakh, Z. Dorey-Stein, J.K. Thomas, L.Y.H. Criner, and G.J. Criner

Endobronchial Valves for Severe Emphysema: 24-Month Results of the Emprove Trial
G.J. Criner, A. Delage, K.G. Voelker, and EMPROVE Trial Investigator Group

Impact of the Lung Allocation Score on Transplant Waitlist Mortality for Sarcoidosis
M.Zheng, C.N. Myers, A.J. Gangemi, H.Zhao, K. Mittal, F.C. Cordova, G.J. Criner, A.J. Mamary, R.Gupta

Lung Transplantation Waitlist Mortality Among Patients with Sarcoidosis Compared to Those with Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease in the Post-Lung Allocation Score Era
C.N. Myers, A.J. Gangemi, M. Zheng, H. Zhao, R. Gupta, F.C. Cordova, G.J. Criner, and A.J. Mamary

Short-Term Outcomes of Patients Receiving Lung Transplantation After Being Declined as High-Risk Candidates Elsewhere
R. Marron, M. Patel, Z. Dorey-Stein, C.N. Myers, N. Mills, J.M. Chowdhury, S. Codella, P. Varghese, S. Priest, H. Zhao, P. Mullhall, J. Galli, K.V. Shenoy, G.J. Criner, N. Marchetti, J.C. Brown, S. Sehgal, F.C. Cordova, and A.J. Mamary

Impact of DVT Prophylaxis Interruption on VTE Incidence Post Lung Transplant
I. Yousef, M. Zheng, S. Sehgal, A.J. Mamary, and P. Rali

Impact of Pre-Transplant Anti-Fibrotic Therapy for IPF Upon Lung Transplant Outcomes
T.L. Astor, H.J. Goldberg, L. Snyder, A. Courtwright, R. Hachem, T. Pena, L. Zaffiri, G.J. Criner, M.M. Budev, T. Thaniyavarn, H.M. Lazarus, S. Bender, A. Barakat, J. Breeze, and P. LaCamera

Phenotypic Characteristics and Clinical Outcomes Among Individuals with COPD and Polycythemia
A Fawzy, H.J. Woo, A. Balasubramanian, I. Barjaktarevic, R.G. Barr, R.P. Bowler, A.P. Comellas, G.J. Criner, M.T. Dransfield, M.K. Han, E.A. Hoffman, R.E. Kanner, J.A. Krishnan, W.K. O’Neal, R. Paine, S.P. Peters, P. Woodruff, N.N. Hansel, and N. Putcha

Nuetrophil to Lymphocyte Ratio (NLR) Is a Potential Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS Cohort
D. Hoesterey, H. Dang, R.G Barr, J.A. Belperio, R.P. Bowler, R.G. Buhr, D. Couper, G.J. Criner, C.M. Doerschuk, M.T. Dransfield, M.B. Drummond, C.M. Freeman, M.K. Han, N.N. Hansel, A.T. Hastie, E.A. Hoffman, R.J. Kaner, R.E. Kanner, V. Kim, J.A. Krishnan, F.J.Martinez, W.K. O’Neal, V.E. Ortega, R. Paine, D.P. Tashkin, J.M. Wells, P. Woodruff, J.L. Curtis, I. Barjaktarevic, and SPIROMICS Investigators

Plasma GDF-15 Levels Improve Risk Assessments for Severe COPD Outcomes
B. Masters, J.L. Curtis, M.K. Han, F.J. Martinez, W.K. O’Neal, C.M. Freeman, G.J. Criner, M.T. Dransfield, R.P. Bowler, D. Coupers, W.W. Labaki, N.N. Hansel, S.P. Peters, P. Woodruff, S.P. Bhatt, T.M. Siler, M. Miller, and J.E. Herrera

FEV1SVC Ratio Below 0.7 Is Associated with Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers with Normal Spirometry
S. Fortis, A.P. Comellas, S.P. Bhatt, E.A. Hoffman, M.K. Han, N.R. Bhakta, B. Ronish, M.T. Dransfield, D. Hoesterey, R.G. Barr, R.G. Buhr, S.P. Peters, D. Couper, M. Arjomandi, M.B. Drummond, R.J. Kaner, R.E. Kanner, V. Kim, V.E. Ortega, D.P. Tashkin, B. Dolezal, J.L. Curtis, R.P. Bowler, F.J. Martinez, W.W. Labaki, C.B. Cooper, G.J. Criner, R. Paine, N.N. Hansel, P. Woodruff, and I. Barjaktarevic

Patient-Reported Clinical Variables Associated with Significant Air Trapping in Smokers: An Analysis of the SPIROMICS Cohort
S. Putcha, T. Gu, S. Murray, C.A. Meldrum, J. Cardenas-Garcia, J.L. Curtis, F.J. Martinez, G.J. Criner, R.P. Bowler, R.G. Barr, E.A. Hoffman, A. Fawzy, N. Putcha, N.N. Hansel, E.R. Bleecker, I. Barjaktarevic, R.E. Kanner, R. Paine, M.T. Dransfield, J.A. Krishnan, V.E. Ortega, S.P. Peters, W.K. O'Neal, M. Arjomandi, P. Woodruff, M.K. Han, and W.W. Labaki

Baseline Assessment of Chronic Bronchitis by SGRQ Has Similar Predictive Value for COPD Exacerbations Compared with Serial Assessments
V. Kim, H. Zhao, I. Barjaktarevic, C.B. Cooper, J.L. Curtis, N.N. Hansel, R.E. Kanner, F.J. Martinez, R. Paine, R.A. Wise, P. Woodruff, G.J. Criner, and The SPIROMICS Investigators

Defining and Investigating “Resilience” to the Pulmonary Effects of Smoking in Spiromics
A. Oh, R.A. Mularski, S. Christenson, I. Barjaktarevic, R.G. Barr, R.P. Bowler, A.P. Comellas, G.J. Criner, M.T. Dransfield, M.K. Han, N.N. Hansel, J.A. Krishnan, R. Paine, S.P. Peters, and P. Woodruff

Characteristics and Outcomes of Patients with Pulmonary Embolism Who Receive Inferior Vena Cava Filter Placement for Classic and Expanded Indications
L.P. Vien, R.M. Marron, C. Guo, R. Cobb, J. Panaro, G. Cohen, G.J. Criner, and P. Rali

Hospital Length of Stay Among Intermediate-Risk Pulmonary Embolism Patients Undergoing Catheter-Directed Therapy Versus Anticoagulation Alone
P. Khaing, L.P. Vien, J. Uricheck, R. Alashram, C. Gonsalves, J. Eisenbrey, X. Lu, H. Zhao, P. Rali, and B.K. Awsare

Ambient Pollution Exposure and Sleep Quality in Spiromics
A.L. Koch, N. Putcha, H. Woo, L.M. Paulin, R.G. Barr, A.P. Comellas, C.B. Cooper, I. Barjaktarevic, M.R. Zeidler, M.E. Billings, R.P. Bowler, A.D. Baugh, M.K. Han, V. Kim, R. Paine, M.T. Dransfield, J.A. Krishnan, S.P. Peters, N.M. Punjabi, P. Woodruff, J.D. Kaufman, N.N. Hansel

Histological Assessment of Remaining Terminal Bronchioles in PRMfSAD-Dominant Regions
D.M. Vasilescu, N. Marchetti, C.J. Galban, C. Hatt, C.A. Meldrum, P. Jingwen, L. Stacey, F. Chu, D. Chandra, R.M. Rishindra, B.D. Ross, W.W. Labaki, E.A. Kazerooni, G.J. Criner, F.J. Martinez, J.L. Curtis, T.-L. Hackett, J.C. Hogg, and M.K. Han

Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort
N. Yee, D. Markovic, R.G. Buhr, D.P. Tashkin, S.P. Bhatt, S. Fortis, M. Arjomandi, B. Ronish, D. Couper, W.H. Anderson, R.E. Kanner, R. Paine, R.J. Kaner, W.K. O'Neal, P. Woodruff, M.K. Han, F.J. Martinez, R.G. Barr, J.M. Wells, V.E. Ortega, E.A. Hoffman, V. Kim, M.B. Drummond, R.P. Bowler, G.J. Criner, J.L. Curtis, C.B. Cooper, and I. Barjaktarevic

Lung Volumes Differences Across GOLD Stages of COPD in VA Electronic Health Records, COPDGene, and SPIROMICS
M. Arjomandi, S. Zeng, I. Mogilnicka, I. Barjaktarevic, R.G. Barr, N.R. Bhakta, E.R. Bleecker, R.P. Bowler, R.G. Buhr, G.J. Criner, A.P. Comellas, C.B. Cooper, D. Couper, J.L. Curtis, M.T. Dransfield, S. Fortis, M.K. Han, N.N. Hansel, E.A. Hoffman, J.E. Hokanson, R.J. Kaner, R.E. Kanner, J.A. Krishnan, S.C. Lazarus, D.A. Lynch, R. Paine, S.P. Peters, M. Ragland, E.A. Regan, S.I. Rennard, and P. Woodruff

Caveolin-1-Derived Peptide Limits Development of Pulmonary Fibrosis
S. Shetty, A. Marudamuthu, Y. Bhandary, L. Fan, V. Radhakrishnan, B. MacKenzie, E. Maier, S.K. Shetty, V. Gopu, N. Tiwari, Y. Zhang, A.B. Watts, R.O.I. Williams, S. Idell, G.J. Criner, S. Bolla, N. Marchetti, and M.R. Nagaraja

Intermediate (CD14++ CD16+) Monocytes Correlate with Parametric Response Mapping of Functional Small Airways Disease: Spiromics Immunophenotyping Sub-Study
C.M. Freeman, J.P. Brown, M.R. Kady, V.R. Stolberg, M.S. Toma, N.E. Alexis, M. Arjomandi, I. Barjaktarevic, R.G. Barr, E.R. Bleecker, R.P. Bowler, S. Christenson, A.P. Comellas, D. Couper, G.J. Criner, C.M. Doerschuk, M.T. Dransfield, M.K. Han, A.T. Hastie, E.A. Hoffman, R.J. Kaner, R.J. Kaner, J.A. Krishnan, W.W. Labaki, F.J. Martinez, D.A. Meyers, W.K. O'Neal, R. Paine, V. Tejwani, J.M. Wells, P. Woodruff, and J.L. Curtis

Factors Affecting Virtual Bronchoscopic Navigation Diagnostic Yield of Pulmonary Nodules in Patients with Advanced Lung Disease
R. Marron, S. Verga, C. Veselis, C.-Y.C. Guo, J.A. Ramzy, J. Thomas, C. Dass, and G.J. Criner

Endobronchial Obstruction by Fibrotic Webbing in a Patient with Sarcoidosis and Mycobacterium Avium
K.U. Lio, A.J. Gangemi, and E. Narewski

Mimic of Chronic Thromboembolic Pulmonary Hypertension in Sarcoidosis: Pulmonary Hypertension from Compressive Lymphadenopathy
A. Karanam, I. Oriaku, and R. Gupta

End Stage Pulmonary Sarcoidosis: Pulmonary Hemodynamics and Lung Transplantation Wait List Mortality
M. Zheng, A.J. Gangemi, C.N. Myers, H. Zhao, K. Mittal, F.C. Cordova, G.J. Criner, R. Gupta, A.J. Mamary

Retrospective Analysis of Primary Causes for Hospitalizations in Patients with Sarcoidosis in Temple Health Care Systems
M. Patel, Z. Dorey-Stein, A. Karanam, I. Oriaku, T. Bronzell-wynder, S. Dubal, K. Mittal, and R. Gupta

A Multimodal Resuscitative Approach for Concurrent Antihypertensive and Antipsychotic Drug Toxicity
E.-O. Essien, M.A. Ondeck, J. Galli, and C.L. Vaz

Diffuse Alveolar Hemorrhage: The Road Less Traveled
N.A. Kaur, M. Zheng, and P.B. Desai

Rare Case of Spontaneous Mediastinal Hematoma
G. Berardi, D. Madnick, E. Dominguez Castillo, and S. Sehgal

K2: A Case of Unintended Consequences
B. Ferraro, A. Patel, M. Botejue, J. Yao-Chieh.Cheng, R. Parth, and M. Gordon

Inferior Vena Cava Filter Usage and Outcomes in Patients with Pulmonary Embolism Before and After Implementation of a Pulmonary Embolism Response Team
R. Marron, L.P. Vien, C.-Y.C. Guo, R. Cobb, J. Panaro, G.S. Cohen, G.J. Criner, and P. Rali

Tracking Perfusion Changes with 99mTc-maa Spect/CT Perfusion Lung Scan Following Acute Pulmonary Embolism - How and When?
E. Harrison, S. Pettigrew, D. Posocco, K. Maruti, B. Kamat, H. Zhao, G.J. Criner, S. Dadparvar, S.E. Weaver, and P. Rali

Case Series of Elderly Patients Treated with Catheter Directed Thrombolysis (CDT) for Pulmonary Embolism (PE) at Large Tertiary Care Center
J.S. Kim, M. Patel, E. Harrison, R. Alashram, J. Panaro, G.S. Cohen, R. Bashir, K. Mohrien, K.U. Lio, G.J. Criner, and P. Rali

The Accuracy of Non-Radiologists at Identifying Signs of Right Heart Strain on Computer Tomography Angiography (CTA) of Patients with Acute Pulmonary Embolism (PE)
S. Pettigrew, E. Harrison, L.P. Vien, E.-O. Essien, I. Yousef, M. Patel, M. Zheng, R. Alashram, H. Zhao, G.J. Criner, M. Kumaran, and P. Rali

Acute Pulmonary Embolism Causes Pulmonary Artery Enlargement
R. Alashram, C. Dass, M. Kumaran, J.H. Hwang, G. Millio, G.J. Criner, and P. Rali

Left Atrial Volume Index as a Predictor of Reperfusion Therapy in Acute Pulmonary Embolus
M. Patel, Z. Dorey-Stein, A.J. Noory, D. Gaballa, H. Zhao, A.J. Gangemi, P. Patil, and P. Rali

Interstitial Emphysema as a Rare Radiographic Presentation of Bronchial Dehiscence After Lung Transplant
L. Vien, R.M. Marron, A. Charlie, M. Kumaran, and J.C. Brown

Mold on the Brain: Disseminated Cryptococcal Infection Presenting as Failure to Thrive and Leading to Death in a Lung Transplant Recipient
A. Karanam, K. Mittal, S. Sehgal, and R. Gupta

A Diagnostic Dilemma: When Differentiating Infection and Malignancy Becomes Difficult!
N.A. Kaur, A. Adika, M. Patel, R. Gupta, and K.V. Shenoy

Antibody Mediated Rejection in a Lung Transplant Patient: Where Are the Antibodies?
P. Varghese, M. Patel, C.N. Myers, P. Mulhall, and J.C. Brown

Serious Pneumothorax Events Following Bronchoscopic Lung Volume Reduction with Endobronchial Valves
G.J. Criner, M.T. Dransfield, F.C. Sciurba, P.L. Shah, M. Wahidi, B. Armstrong, and D.-J. Slebos

Physician Reimbursement vs Procedural Effort for Bronchoscopic Lung Volume Reduction with Endobronchial Valves in Clinical Practice
Z. Dorey-Stein, M. Patel, A.J. Gangemi, M. Zantah, E. Dominguez Castillo, A. Pandya, R. Marron, S. Verga, M. Zheng, N. Patlakh, L.-Y.H. Criner, J. Thomas, N. Marchetti, and G.J. Criner

Static and Dynamic Hyperinflation in Patients Undergoing Evaluation for Bronchoscopic Lung Volume Reduction with Severe Hyperinflation and Advanced Emphysema
Z. Dorey-Stein, M. Patel, A.J. Gangemi, M. Zantah, E. Dominguez Castillo, A. Pandya, J. Thomas, N. Patlakh, L.-Y.H. Criner, R. Marron, S. Verga, M. Zheng, N. Marchetti, and G.J. Criner

Derivation of a Machine Learning Model to Identify Patients at Low Risk for Pneumothorax Following Bronchoscopic Lung Volume Reduction
A. Pandya, S. Aronoff, A.J. Gangemi, N.J. Patlakh, E. Dominguez Castillo, M. Patel, Z. Dorey-Stein, M. Zheng, L.-Y.H. Criner, J. Thomas, and G.J. Criner

Evaluation of the Safety of Systemic Anticoagulation in Patients Receiving Catheter Directed Thrombolysis (CDT) for Intermediate Risk Pulmonary Embolism (PE)
P. Rali, H. Choi, M. Varu, C. Rose, P. Dubal, K. Mohrien, and G.J. Criner

Massive Alveolar Hemorrhage Presenting After IVC Filter Strut Lodged in Pulmonary Artery
R. Prosniak, S. Verga, R. Gupta, and S.L. Krachman

E-cigarette or Vaping Product Use Associated Lung Injury: A Rare Association with Cardiac Thrombus
O. Sheriff, R.W. Hooper, and J.L. Garfield

Effects of Bronchoscopic Lung Volume Reduction with Endobronchial Valves on Diaphragm Length
M. Zheng, M. Patel, Z. Dorey-Stein, E. Dominguez Castillo, A.J. Gangemi, M. Zantah, A. Pandya, R. Marron, S. Verga, J.K. Thomas, L.-Y.H. Criner, N. Patlakh, N. Marchetti, and G.J. Criner

Insights from Mid-Expiratory Flow Rate (FEF25-75%) in Ever-Smokers with Preserved Lung Function in the Subpopulations and Intermediate Markers in COPD Study (SPIROMICS) Cohort
B. Ronish, L. Gravens-Mueller, D. Couper, I. Barjaktarevic, C.B. Cooper, R.E. Kanner, C.S. Pirozzi, V. Kim, J.M. Wells, M.K. Han, P. Woodruff, V.E. Ortega, S.P. Peters, R.G. Buhr, B. Dolezal, L.A. Bateman, F.J. Martinez, R.G.G. Barr, N.N. Hansel, A.P. Comellas, J.L. Curtis, and R. Paine

Does Race Adjustment in Pulmonary Function Testing Obscure Important Disparities?
A. Baugh, I. Barjaktarevic, R.G. Barr, G.J. Criner, A.P. Comellas, C.B. Cooper, D. Couper, M.K. Han, N.N. Hansel, E.A. Hoffman, D.M. Mannino, J.A. Krishnan, R. Paine, S.I. Rennard, N. Thakur, P. Woodruff, and SPIROMICS Investigators